Cargando…

BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer

Detalles Bibliográficos
Autores principales: Lochmann, Timothy L, Bouck, Ynes M, Faber, Anthony C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142900/
https://www.ncbi.nlm.nih.gov/pubmed/30234143
http://dx.doi.org/10.18632/oncoscience.455
_version_ 1783355920024076288
author Lochmann, Timothy L
Bouck, Ynes M
Faber, Anthony C
author_facet Lochmann, Timothy L
Bouck, Ynes M
Faber, Anthony C
author_sort Lochmann, Timothy L
collection PubMed
description
format Online
Article
Text
id pubmed-6142900
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-61429002018-09-19 BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer Lochmann, Timothy L Bouck, Ynes M Faber, Anthony C Oncoscience Research Perspective Impact Journals LLC 2018-08-14 /pmc/articles/PMC6142900/ /pubmed/30234143 http://dx.doi.org/10.18632/oncoscience.455 Text en Copyright: © 2018 Lochmann et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Perspective
Lochmann, Timothy L
Bouck, Ynes M
Faber, Anthony C
BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title_full BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title_fullStr BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title_full_unstemmed BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title_short BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer
title_sort bcl-2 inhibition is a promising therapeutic strategy for small cell lung cancer
topic Research Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142900/
https://www.ncbi.nlm.nih.gov/pubmed/30234143
http://dx.doi.org/10.18632/oncoscience.455
work_keys_str_mv AT lochmanntimothyl bcl2inhibitionisapromisingtherapeuticstrategyforsmallcelllungcancer
AT bouckynesm bcl2inhibitionisapromisingtherapeuticstrategyforsmallcelllungcancer
AT faberanthonyc bcl2inhibitionisapromisingtherapeuticstrategyforsmallcelllungcancer